Treatment for 24 months with recombinant human GH has a beneficial effect on bone mineral density in young adults with childhood-onset GH deficiency. [electronic resource]
Producer: 20090602Description: 899-907 p. digitalISSN:- 1479-683X
- Absorptiometry, Photon
- Adolescent
- Adult
- Age of Onset
- Alkaline Phosphatase -- metabolism
- Bone Density
- Bone Remodeling -- physiology
- Bone and Bones -- metabolism
- Female
- Growth Disorders -- drug therapy
- Human Growth Hormone -- adverse effects
- Humans
- Insulin-Like Growth Factor I -- metabolism
- Male
- Recombinant Proteins -- adverse effects
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.